JIC
XTNT icon

Johnson Investment Counsel’s Xtant Medical Holdings XTNT Stock Holding History

Johnson Investment Counsel’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-125
Closed -$6K – 531
2013
Q2 		$6K Buy
+125
New +$10.3K ﹤0.01% 509

Other funds holding XTNT

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Johnson Investment Counsel's XTNT Position: Q3 2013 in Review

Johnson Investment Counsel sold out of Xtant Medical Holdings (XTNT) in Q3 2013, closing a stake of 125 shares — an estimated $6K sold.

Johnson Investment Counsel first reported a position in XTNT in Q2 2013 and held it in 1 quarter. The position peaked at $6K in Q2 2013. 20 funds tracked by Wall St. Rank hold XTNT as of Q3 2013.

  • Johnson Investment Counsel reported no remaining Xtant Medical Holdings position as of Q3 2013 after selling out during the quarter.
  • Johnson Investment Counsel sold 125 Xtant Medical Holdings shares in Q3 2013, an estimated $6K.
  • Johnson Investment Counsel first reported a position in Xtant Medical Holdings in Q2 2013 and held it in 1 quarter.
  • Johnson Investment Counsel's Xtant Medical Holdings position peaked at $6K in Q2 2013.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2013.

Based on Johnson Investment Counsel's 13F filing for Q3 2013, filed 13 Nov 2013.